Naltrexone-Bupropion Combination

DRUG4 trials

Sponsors

National and Kapodistrian University of Athens, Zuyderland Medisch Centrum, Columbia University, The Cleveland Clinic

Conditions

Bariatric Surgery CandidateBlood PressureMedication PersistenceObesityObesity, Morbid

Phase 4

Study of the Cardiometabolic Effects of Obesity Pharmacotherapy

National and Kapodistrian University of AthensBlood Pressure, Obesity

Start: 2020-09-08End: 2023-05-30Target: 40Updated: 2020-10-08

Use of Mysimba in Patients With Weight Regain After Bariatric Surgery

Zuyderland Medisch CentrumBariatric Surgery Candidate, Medication Persistence, Obesity, Morbid

Start: 2023-03-21End: 2025-03-31Target: 116Updated: 2023-05-30

Weight Loss Study: Genetics and Response to Naltrexone/Bupropion

RecruitingNCT05919797

Columbia UniversityObesity

Start: 2023-06-08End: 2027-06-30Target: 120Updated: 2026-06-10

Sequential or CombinaTion Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)

Active, not recruitingNCT06854614

The Cleveland ClinicObesity

Start: 2025-03-01End: 2028-04-28Updated: 2025-12-12

Related Papers

Circulating levels of all proglucagon-derived peptides are differentially regulated postprandially by obesity status and in response to high-fat meals vs. high-carbohydrate meals.

2023-06-289 citations